These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8827702)

  • 1. Uptake pathways of clinical isolates of Proteus mirabilis into human epithelial cell lines.
    Oelschlaeger TA; Tall BD
    Microb Pathog; 1996 Jul; 21(1):1-16. PubMed ID: 8827702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some structures and processes of human epithelial cells involved in uptake of enterohemorrhagic Escherichia coli O157:H7 strains.
    Oelschlaeger TA; Barrett TJ; Kopecko DJ
    Infect Immun; 1994 Nov; 62(11):5142-50. PubMed ID: 7523304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasion of cultured human epithelial cells by Klebsiella pneumoniae isolated from the urinary tract.
    Oelschlaeger TA; Tall BD
    Infect Immun; 1997 Jul; 65(7):2950-8. PubMed ID: 9199471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual microtubule-dependent endocytosis mechanisms triggered by Campylobacter jejuni and Citrobacter freundii.
    Oelschlaeger TA; Guerry P; Kopecko DJ
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6884-8. PubMed ID: 8341714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteus mirabilis clinical isolate harbouring a new variant of Salmonella genomic island 1 containing the multiple antibiotic resistance region.
    Ahmed AM; Hussein AI; Shimamoto T
    J Antimicrob Chemother; 2007 Feb; 59(2):184-90. PubMed ID: 17114173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of LPS on epithelial integrity and bacterial uptake in the polarized human enterocyte-like cell line Caco-2.
    Wells CL; Jechorek RP; Olmsted SB; Erlandsen SL
    Circ Shock; 1993 Aug; 40(4):276-88. PubMed ID: 8375030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin.
    Alamuri P; Mobley HL
    Mol Microbiol; 2008 May; 68(4):997-1017. PubMed ID: 18430084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Salmonella typhi and Salmonella typhimurium invasion, intracellular growth and localization in cultured human epithelial cells.
    Mills SD; Finlay BB
    Microb Pathog; 1994 Dec; 17(6):409-23. PubMed ID: 7752882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
    J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection.
    Zunino P; Piccini C; Legnani-Fajardo C
    Microb Pathog; 1994 May; 16(5):379-85. PubMed ID: 7815921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological and therapeutic significance of cellular invasion by Proteus mirabilis in an enterocystoplasty infection stone model.
    Mathoera RB; Kok DJ; Verduin CM; Nijman RJ
    Infect Immun; 2002 Dec; 70(12):7022-32. PubMed ID: 12438382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary pathogenicity of Proteus mirabilis strains isolated from faeces or urine.
    Peerbooms PG; Verweij AM; Oe PL; MacLaren DM
    Antonie Van Leeuwenhoek; 1986; 52(1):53-62. PubMed ID: 3524444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.
    Saito R; Okugawa S; Kumita W; Sato K; Chida T; Okamura N; Moriya K; Koike K
    Clin Microbiol Infect; 2007 Dec; 13(12):1204-6. PubMed ID: 17850340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-encapsulated strains reveal novel insights in invasion and survival of Streptococcus suis in epithelial cells.
    Benga L; Goethe R; Rohde M; Valentin-Weigand P
    Cell Microbiol; 2004 Sep; 6(9):867-81. PubMed ID: 15272867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemagglutinating properties of Proteus mirabilis strains isolated from clinical specimens].
    Samet A; Aleksandrowicz I
    Med Dosw Mikrobiol; 1989; 41(2):121-9. PubMed ID: 2685483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swarmer cell differentiation in Proteus mirabilis.
    Rather PN
    Environ Microbiol; 2005 Aug; 7(8):1065-73. PubMed ID: 16011745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion of Proteus mirabilis and Proteus vulgaris to uroepithelial cells following exposure to various antimicrobial agents.
    Tullio V; Carlone NA; Cuffini AM; Fazari S
    Microbios; 1992; 69(278):67-75. PubMed ID: 1588844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enteropathogenicity of Proteus mirabilis bacteria and pathogenesis of experimental intestinal infections caused by them].
    Bidnenko SI; Bernasovskaia EP; Anisimova IuN; Barshteĭn IuA; Mel'nitskaia EV
    Mikrobiol Zh (1978); 1985; 47(6):81-8. PubMed ID: 3917194
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin-8 response in cells from the human urinary tract induced by lipopolysaccharides of Proteus mirabilis O3 and O18.
    Chromek M; Stankowska D; Dadfar E; Kaca W; Rabbani H; Brauner A
    J Urol; 2005 Apr; 173(4):1381-4. PubMed ID: 15758809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.